These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2084948

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studies.
    Linhardt RJ, Desai UR, Liu J, Pervin A, Hoppensteadt D, Fareed J.
    Biochem Pharmacol; 1994 Mar 29; 47(7):1241-52. PubMed ID: 8161353
    [Abstract] [Full Text] [Related]

  • 23. Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
    Van Ryn-McKenna J, Ofosu FA, Gray E, Hirsh J, Buchanan MR.
    Ann N Y Acad Sci; 1989 Mar 29; 556():304-12. PubMed ID: 2735661
    [Abstract] [Full Text] [Related]

  • 24. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
    Cadroy Y, Dol F, Caranobe C, Petitou M, Lormeau JC, Sié P, Choay J, Boneu B.
    Thromb Haemost; 1988 Apr 08; 59(2):295-8. PubMed ID: 2838927
    [Abstract] [Full Text] [Related]

  • 25. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Maggi A, Abbadini M, Pagella PG, Borowska A, Pangrazzi J, Donati MB.
    Haemostasis; 1987 Apr 08; 17(6):329-35. PubMed ID: 3428718
    [Abstract] [Full Text] [Related]

  • 26. Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities.
    Nader HB, Lopes CC, Rocha HA, Santos EA, Dietrich CP.
    Curr Pharm Des; 2004 Apr 08; 10(9):951-66. PubMed ID: 15078126
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP, Merton RE, Barrowcliffe TW.
    Ann N Y Acad Sci; 1989 Apr 08; 556():313-22. PubMed ID: 2735662
    [Abstract] [Full Text] [Related]

  • 29. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
    Buchanan MR, Brister SJ.
    Thromb Res; 2000 Sep 15; 99(6):603-12. PubMed ID: 10974347
    [Abstract] [Full Text] [Related]

  • 30. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
    Tovar AM, de Mattos DA, Stelling MP, Sarcinelli-Luz BS, Nazareth RA, Mourão PA.
    Biochim Biophys Acta; 2005 Apr 15; 1740(1):45-53. PubMed ID: 15878740
    [Abstract] [Full Text] [Related]

  • 31. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
    Pacheco RG, Vicente CP, Zancan P, Mourão PA.
    Blood Coagul Fibrinolysis; 2000 Sep 15; 11(6):563-73. PubMed ID: 10997797
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.
    Linhardt RJ, al-Hakim A, Liu JA, Hoppensteadt D, Mascellani G, Bianchini P, Fareed J.
    Biochem Pharmacol; 1991 Sep 27; 42(8):1609-19. PubMed ID: 1930287
    [Abstract] [Full Text] [Related]

  • 36. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP, Zancan P, Peixoto LL, Alves-Sá R, Araújo FS, Mourão PA, Pavão MS.
    Thromb Haemost; 2001 Nov 27; 86(5):1215-20. PubMed ID: 11816710
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
    Meuleman DG.
    Semin Thromb Hemost; 1989 Oct 27; 15(4):370-2. PubMed ID: 2479103
    [Abstract] [Full Text] [Related]

  • 39. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits.
    Carter CJ, Kelton JG, Hirsh J, Cerskus A, Santos AV, Gent M.
    Blood; 1982 Jun 27; 59(6):1239-45. PubMed ID: 7082826
    [Abstract] [Full Text] [Related]

  • 40. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
    Wilde MI, Markham A.
    Drugs; 1997 Dec 27; 54(6):903-24. PubMed ID: 9421696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.